Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 5 | $38,759,992 |
| Sells | 15 | $209,459,410 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 13 Nov 2024 20:16 | SPRY | ARS Pharmaceuticals Inc | FLYNN JAMES E | 10% | 11 Nov 2024 | Sale | 40,596 | 17.45 | 708,400 | I |
| 13 Nov 2024 20:16 | SPRY | ARS Pharmaceuticals Inc | FLYNN JAMES E | 10% | 11 Nov 2024 | Sale | 40,596 | 17.45 | 708,400 | I |
| 13 Nov 2024 20:16 | SPRY | ARS Pharmaceuticals Inc | FLYNN JAMES E | 10% | 11 Nov 2024 | Sale | 223,632 | 18.15 | 4,058,921 | I |
| 13 Nov 2024 20:16 | SPRY | ARS Pharmaceuticals Inc | FLYNN JAMES E | 10% | 11 Nov 2024 | Sale | 223,632 | 18.15 | 4,058,921 | I |
| 13 Nov 2024 20:16 | SPRY | ARS Pharmaceuticals Inc | FLYNN JAMES E | 10% | 12 Nov 2024 | Sale | 7,853 | 17.16 | 134,757 | I |
| 13 Nov 2024 20:16 | SPRY | ARS Pharmaceuticals Inc | FLYNN JAMES E | 10% | 12 Nov 2024 | Sale | 7,854 | 17.16 | 134,775 | I |
| 13 Nov 2024 20:16 | SPRY | ARS Pharmaceuticals Inc | FLYNN JAMES E | 10% | 12 Nov 2024 | Sale | 9,554 | 17.77 | 169,775 | I |
| 13 Nov 2024 20:16 | SPRY | ARS Pharmaceuticals Inc | FLYNN JAMES E | 10% | 12 Nov 2024 | Sale | 9,553 | 17.77 | 169,757 | I |
| 24 Oct 2024 16:08 | NUVL | Nuvalent Inc | FLYNN JAMES E | Director , 10% | 22 Oct 2024 | Sale | 1,000,000 | 97.75 | 97,750,000 | I |
| 24 Oct 2024 16:08 | NUVL | Nuvalent Inc | FLYNN JAMES E | Director , 10% | 22 Oct 2024 | Sale | 1,000,000 | 97.75 | 97,750,000 | I |
| 17 Sep 2024 18:16 | BCAX | Bicara Therapeutics Inc | FLYNN JAMES E | 10% | 17 Sep 2024 | Purchase | 35,000 | 18 | 630,000 | I |
| 17 Sep 2024 18:16 | BCAX | Bicara Therapeutics Inc | FLYNN JAMES E | 10% | 17 Sep 2024 | Purchase | 35,000 | 18 | 630,000 | I |
| 12 Mar 2024 19:01 | AHCO | AdaptHealth Corp | FLYNN JAMES E | 10% | 12 Mar 2024 | Sale | 114,906 | 10.7 | 1,229,494 | I |
| 12 Mar 2024 19:01 | AHCO | AdaptHealth Corp | FLYNN JAMES E | 10% | 11 Mar 2024 | Sale | 88,040 | 11.13 | 979,885 | I |
| 12 Mar 2024 19:01 | AHCO | AdaptHealth Corp | FLYNN JAMES E | 10% | 11 Mar 2024 | Sale | 94,567 | 10.92 | 1,032,672 | I |
| 12 Mar 2024 19:01 | AHCO | AdaptHealth Corp | FLYNN JAMES E | 10% | 08 Mar 2024 | Sale | 4,495 | 11.03 | 49,580 | I |
| 12 Mar 2024 19:01 | AHCO | AdaptHealth Corp | FLYNN JAMES E | 10% | 08 Mar 2024 | Sale | 47,992 | 10.92 | 524,073 | I |
| 16 Feb 2024 14:37 | LRMR | Larimar Therapeutics Inc | FLYNN JAMES E | Director , 10% | 16 Feb 2024 | Purchase | 1,430,206 | 8.74 | 12,500,000 | I |
| 16 Feb 2024 14:37 | LRMR | Larimar Therapeutics Inc | FLYNN JAMES E | Director , 10% | 16 Feb 2024 | Purchase | 1,430,205 | 8.74 | 12,499,992 | I |
| 16 Feb 2024 14:37 | LRMR | Larimar Therapeutics Inc | FLYNN JAMES E | Director , 10% | 16 Feb 2024 | Purchase | 1,430,206 | 8.74 | 12,500,000 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)